Table I.
miR-545 | ||||
---|---|---|---|---|
Characteristics | Cases | High | Low | P-value |
Age (years) | 0.072 | |||
≥60 | 54 | 20 | 34 | |
<60 | 30 | 12 | 18 | |
Sex | 0.21 | |||
Male | 50 | 21 | 29 | |
Female | 34 | 16 | 18 | |
Tumor size (mm) | 0.144 | |||
≤3 | 48 | 22 | 26 | |
>3 | 36 | 15 | 21 | |
Lymph node metastasis | 0.016a | |||
Yes | 19 | 7 | 12 | |
No | 65 | 25 | 40 | |
Tumor stage | 0.02a | |||
I–II | 60 | 24 | 36 | |
III–IV | 24 | 10 | 14 |
Statistical analyses were performed by the χ2 test.
P<0.05 was considered statistically significant. miR-545, microRNA-545; NSCLC, non-small cell lung cancer.